Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Gry A. Geitvik"'
Autor:
Hege O. Ohnstad, Elin Borgen, Ragnhild S. Falk, Tonje G. Lien, Marit Aaserud, My Anh T. Sveli, Jon A. Kyte, Vessela N. Kristensen, Gry A. Geitvik, Ellen Schlichting, Erik A. Wist, Therese Sørlie, Hege G. Russnes, Bjørn Naume
Publikováno v:
Breast Cancer Research, Vol 19, Iss 1, Pp 1-12 (2017)
Abstract Background The aim of this study was to investigate the prognostic value of the PAM50 intrinsic subtypes and risk of recurrence (ROR) score in patients with early breast cancer and long-term follow-up. A special focus was placed on hormone r
Externí odkaz:
https://doaj.org/article/a45dab2fcc384c7eab60ce8a11289adf
Autor:
Wanja Kildal, Karolina Cyll, Joakim Kalsnes, Rakibul Islam, Frida M. Julbø, Manohar Pradhan, Elin Ersvær, Neil Shepherd, Ljiljana Vlatkovic, Xavier Tekpli, Øystein Garred, Gunnar B. Kristensen, Hanne A. Askautrud, Tarjei S. Hveem, Håvard E. Danielsen, Tone F. Bathen, Elin Borgen, Anne-Lise Børresen-Dale, Olav Engebråten, Britt Fritzman, Olaf Johan Hartman-Johnsen, Jürgen Geisler, Gry Aarum Geitvik, Solveig Hofvind, Rolf Kåresen, Anita Langerød, Ole Christian Lingjærde, Gunhild M. Mælandsmo, Bjørn Naume, Hege G. Russnes, Kristine Kleivi Sahlberg, Torill Sauer, Helle Kristine Skjerven, Ellen Schlichting, Therese Sørlie
Publikováno v:
Heliyon, Vol 10, Iss 13, Pp e32529- (2024)
We aimed to develop deep learning (DL) models to detect protein expression in immunohistochemically (IHC) stained tissue-sections, and to compare their accuracy and performance with manually scored clinically relevant proteins in common cancer types.
Externí odkaz:
https://doaj.org/article/e0dc5fe8cfec49769db7555ff4402d86
Autor:
Aldema Sas‐Chen, Miriam R Aure, Limor Leibovich, Silvia Carvalho, Yehoshua Enuka, Cindy Körner, Maria Polycarpou‐Schwarz, Sara Lavi, Nava Nevo, Yuri Kuznetsov, Justin Yuan, Francisco Azuaje, Oslo Breast Cancer Research Consortium (OSBREAC), Igor Ulitsky, Sven Diederichs, Stefan Wiemann, Zohar Yakhini, Vessela N Kristensen, Anne‐Lise Børresen‐Dale, Yosef Yarden, Torill Sauer, Jürgen Geisler, Solveig Hofvind, Tone F Bathen, Elin Borgen, Olav Engebråten, Øystein Fodstad, Øystein Garred, Gry Aarum Geitvik, Rolf Kåresen, Bjørn Naume, Gunhild Mari Mælandsmo, Hege G Russnes, Ellen Schlichting, Therese Sørlie, Ole Christian Lingjærde, Kristine Kleivi Sahlberg, Helle Kristine Skjerven, Britt Fritzman
Publikováno v:
EMBO Molecular Medicine, Vol 8, Iss 9, Pp 1052-1064 (2016)
Abstract Long noncoding RNAs (lncRNAs) are emerging as regulators of gene expression in pathogenesis, including cancer. Recently, lncRNAs have been implicated in progression of specific subtypes of breast cancer. One aggressive, basal‐like subtype
Externí odkaz:
https://doaj.org/article/4f7cfb1585b94dd5ac5eed26ab401081
Autor:
Robert Lesurf, Miriam Ragle Aure, Hanne Håberg Mørk, Valeria Vitelli, Torill Sauer, Jürgen Geisler, Solveig Hofvind, Elin Borgen, Anne-Lise Børresen-Dale, Olav Engebråten, Øystein Fodstad, Øystein Garred, Gry Aarum Geitvik, Rolf Kåresen, Bjørn Naume, Gunhild Mari Mælandsmo, Hege G. Russnes, Ellen Schlichting, Therese Sørlie, Ole Christian Lingjærde, Vessela Kristensen, Kristine Kleivi Sahlberg, Helle Kristine Skjerven, Britt Fritzman
Publikováno v:
Cell Reports, Vol 16, Iss 4, Pp 1166-1179 (2016)
Breast cancer consists of at least five main molecular “intrinsic” subtypes that are reflected in both pre-invasive and invasive disease. Although previous studies have suggested that many of the molecular features of invasive breast cancer are e
Externí odkaz:
https://doaj.org/article/e1867481a54a4882a2cb85fa9be85ee8
Autor:
Vessela N. Kristensen, Gry A. Geitvik, Christin Johansen, Kjetil Boye, Eivind Hovig, Sigve Nakken, Anne Hansen Ree, Gunhild Mari Mælandsmo, Daniel Heinrich, Vigdis Nygaard, Ole Christian Lingjærde, Svein Dueland, Vivi Ann Flørenes, Anne Negård, Anne Lise Børresen-Dale, Lars Julsrud, Claudius H Reisse, Vegard Nygaard, Salah Nasser, Hege G. Russnes, Klaus Beiske, Kjersti Flatmark, Inger Riise Bergheim, Marius Lund-Iversen, Espen A. Ruud
Background: In precision cancer medicine, the challenge is to prioritize DNA driver events, account for resistance markers, and procure sufficient information for treatment that maintains patient safety. The MetAction project, exploring how tumor mol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70ffea2a9af6ed559a75c4a2b4aee573
https://hdl.handle.net/10037/18698
https://hdl.handle.net/10037/18698
Autor:
Gunhild Mari Mælandsmo, Daniel Heinrich, Gry A. Geitvik, Christin Johansen, Klaus Beiske, Vegard Nygaard, Vigdis Nygaard, Anne Hansen Ree, Marius Lund-Iversen, Eivind Hovig, Sigve Nakken, Menaka Sathermugathevan, Ole Christian Lingjærde, Inger Riise Bergheim, Anne Lise Børresen-Dale, Hege G. Russnes, Vivi Ann Flørenes, Svein Dueland, Kjersti Flatmark, Kjetil Boye
Publikováno v:
Molecular Cancer Therapeutics. 17:A101-A101
Background: The first phase of the MetAction trial established the required diagnostic infrastructure, implemented security-approved systems for handling of sensitive information, educated the Trial Team within the context of tumor boards, and estima
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::89e85625f0a520b5a614d49338230ab1
https://doi.org/10.1158/1535-7163.targ-17-a101
https://doi.org/10.1158/1535-7163.targ-17-a101
Autor:
Anne Hansen Ree, Gry A. Geitvik, Anne Lise Børresen-Dale, Vigdis Nygaard, Vegard Nygaard, Ole Christian Lingjærde, Inger Riise Bergheim, Kjetil Boye, Eivind Hovig, Sigve Nakken, Hege G. Russnes, Kjersti Flatmark, Christin Johansen, Klaus Beiske, Vivi Ann Flørenes, Marius Lund-Iversen, Menaka Sathermugathevan, Svein Dueland, Gunhild Mari Mælandsmo, Daniel Heinrich
Publikováno v:
Journal of Clinical Oncology. 35:e14033-e14033
e14033 Background: The MetAction project consists of two clinical trial phases. The completed first phase established the required diagnostic infrastructure, implemented security-approved systems for handling of sensitive information, educated the en
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93f5c3726bb938ed899a9fc30fe4972b
https://doi.org/10.1200/jco.2017.35.15_suppl.e14033
https://doi.org/10.1200/jco.2017.35.15_suppl.e14033
Autor:
Anne Lise Børresen-Dale, Lars Julsrud, Inger Riise Bergheim, Kirsten T. Hagene, Espen A. Ruud, Menaka Sathermugathevan, Klaus Beiske, Salah Nasser, Gunhild Mari Mælandsmo, Daniel Heinrich, Veronica Skarpeteig, Christin Johansen, Kjersti Flatmark, Torill Sauer, Claudius H Reisse, Einar Andreas Rødland, Gry A. Geitvik, Vivi Ann Flørenes, Olga Østrup, Hilde Lurås, Vigdis Nygaard, Eivind Hovig, Janne Merete Torset Øien, Svein Dueland, Kjetil Boye, Eline Aas, Marius Lund-Iversen, Siv Johnsen-Soriano, Sigve Nakken, Ole Christian Lingjærde, Laxmi Silwal-Pandit, Hege G. Russnes, Vegard Nygaard, Anne Hansen Ree
Publikováno v:
ESMO Open
Objective Through the conduct of an individual-based intervention study, the main purpose of this project was to build and evaluate the required infrastructure that may enable routine practice of precision cancer medicine in the public health service
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb226ce2bb46dbea01bfeeb68c871f9f
https://doi.org/10.1136/esmoopen-2017-000158
https://doi.org/10.1136/esmoopen-2017-000158